Oral Lactobacillus reuteri Combined With Intravenous Lysis-Circuit-Bearing Engineered Bacteria RE Enhances Antitumor Efficacy
{{output}}
Engineered bacteria can preferentially colonize hypoxic tumors, but improving efficacy while limiting systemic bacterial burden remains a central challenge. Here, we combined oral Lactobacillus reuteri (LR) with intravenous administration of RE, an engineered ... ...
